Walgreens Boots Alliance(US:WBA) Prnewswire·2024-07-25 09:45Core Viewpoint - Walgreens Boots Alliance, Inc. has faced significant challenges in its U.S. Retail Pharmacy business, leading to a reduction in revenue guidance for Q4 and the full fiscal year 2024, which has resulted in a stock price drop of over 20% following the announcement of its 3Q24 financial results [1]. Group 1 - The class period for shareholders who purchased shares of Walgreens is from October 12, 2023, to June 26, 2024 [1]. - Walgreens announced its 3Q24 financial results on June 27, 2024, which included a lowered revenue guidance due to a worse-than-expected consumer environment and challenging pharmacy industry trends [1]. - Following the announcement, Walgreens stock traded at more than 20% lower than the previous day's closing price of $15.65 per share [1]. Group 2 - Shareholders are encouraged to register for a class action lawsuit, with a deadline to seek lead plaintiff status set for September 10, 2024 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the lifecycle of the case [2]. Group 3 - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who incurred losses from misleading statements or omissions by companies [3].